Evidence map›Paper›PMID 42737738›Full record

ReviewInternational journal of molecular sciences2026

Research Progress on Angiogenesis and Involution Mechanisms of Infantile Hemangioma and Its Regulation by Active Components of

Yuan Lu, Yamin Wu, Nan Gu, Ke Wen, Chao Yang, Xuetao Huang, Dedong Zeng, Lu Huang, Shimin Wu, Shumin Ma and 1 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuan LuIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Yamin WuIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Nan GuIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Ke WenIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Chao YangIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID 0000-0001-7389-1367
Xuetao HuangIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Dedong ZengIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Lu HuangIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Shimin WuIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Shumin MaCentre for Translational Medicine, College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Qian LiuIntegrated Chinese and Western Medicine Institute for Children Health & Drug Innovation, Discipline of Chinese and Western Integrative Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.

Funding

Jiangxi University of Chinese Medicine Doctoral Research Start-up Fund 2023BSZR031the Early-Career Young Scientists and Technologists Project of Jiangxi Province 20252BEJ730080the Foundation of Jiangxi Educational Committee GJJ2400829the Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Program CXTD22014the National Major Scientific Research Cultivation Project of Jiangxi University of Traditional Chinese Medicine 2023ZDPY0011the Science and Technology Plan Project of Jiangxi Provincial Administration of Traditional Chinese Medicine 2025021653the Science and Technology Plan Project of Jiangxi Provincial Administration of Traditional Chinese Medicine 2025021821
6 · The paper itself

Abstract

Infantile hemangioma (IH) is the most common benign vascular tumor of infancy, characterized by a unique life cycle encompassing a rapid proliferative phase followed by spontaneous involution. Although the majority of cases exhibit a favorable prognosis, a small subset may be complicated by severe sequelae that adversely affect the physical and mental health of affected infants. Accumulating evidence indicates that the pathogenesis of IH involves a dynamic imbalance between angiogenesis and involution, which is tightly governed by the multilineage differentiation of hemangioma stem cells, core signaling pathway networks, and epigenetic regulation mediated by non-coding RNAs. A deeper understanding of the mechanisms underlying angiogenesis and involution will provide novel insights into both the fundamental biology and clinical management of IH. Furthermore, multiple bioactive constituents of the traditional Chinese medicine

Indexed as

Drugs, Chinese HerbalHemangiomaNeovascularization, PathologicSalvia miltiorrhizaAnimalsHumansInfantSignal TransductionDrugs, Chinese Herbalactive components of Salvia miltiorrhizaangiogenesisinfantile hemangiomainvolution mechanismsregulatory mechanisms

Identifiers

PMID42737738
PMCPMC13565794

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.